Lateefat Tiwalade Adele, MSN, PMHNP
Psychiatric/Mental Health · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lateefat Tiwalade Adele’s office at (916) 277-9010 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$50,595
Pharmacies billed $50,595 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 225) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
192 generic and 33 brand-name prescriptions · $50,595 in drug cost · 39 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 16 | $26,240 | $1,640 |
| Asenapine Maleate | 17 | $2,039 | $120 |
| Aripiprazole | 14 | $1,038 | $74 |
| Sertraline | 25 | $615 | $25 |
| Bupropion Xl | 11 | $367 | $33 |
See all 7 drugs
| Vraylar | 16 | $26,240 | $1,640 |
| Asenapine Maleate | 17 | $2,039 | $120 |
| Aripiprazole | 14 | $1,038 | $74 |
| Sertraline | 25 | $615 | $25 |
| Bupropion Xl | 11 | $367 | $33 |
| Gabapentin | 15 | $318 | $21 |
| Hydroxyzine | 20 | $147 | $7 |
Money from drug and device companies
$2,268 in 2025
| 2025 | 15 | 76 | None | $2,268 |
| 2024 | 9 | 67 | None | $1,591 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $707 | 31 payments
|
| Teva Pharmaceuticals USA | Uzedy | $573 | 12 payments
|
| Otsuka America Pharmaceutical | Rexulti | $215 | 7 payments
|
| Neurocrine BioSciences | Ingrezza | $173 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $142 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $100 | 4 payments
|
See all 76 published payments
| Vanda Pharmaceuticals | Meals · 2025-12-22 | Hetlioz | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-22 | Caplyta | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-12-18 | Austedo Xr | $117 |
| Teva Pharmaceuticals USA | Meals · 2025-12-16 | Uzedy | $120 |
| Otsuka America Pharmaceutical | Meals · 2025-12-08 | Rexulti | $23 |
| Abbvie | Meals · 2025-11-11 | Vraylar | $28 |
| Teva Pharmaceuticals USA | Meals · 2025-11-10 | Uzedy | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-09 | Caplyta | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-11-04 | Trintellix | $29 |
| Abbvie | Meals · 2025-11-03 | Vraylar | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-11-03 | Uzedy | $9 |
| Supernus Pharmaceuticals | Meals · 2025-10-27 | Qelbree | $16 |
| Abbvie | Meals · 2025-10-21 | Vraylar | $20 |
| Teva Pharmaceuticals USA | Meals · 2025-10-13 | Austedo Xr | $9 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $28 |
| Abbvie | Meals · 2025-09-23 | Vraylar | $21 |
| Lundbeck | Meals · 2025-09-23 | Rexulti | $24 |
| Neurocrine BioSciences | Meals · 2025-09-22 | Ingrezza | $14 |
| Teva Pharmaceuticals USA | Meals · 2025-09-22 | Uzedy | $8 |
| Vanda Pharmaceuticals | Meals · 2025-09-15 | Hetlioz | $17 |
| Abbvie | Meals · 2025-09-09 | Vraylar | $26 |
| Neurocrine BioSciences | Meals · 2025-08-26 | Ingrezza | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-08-25 | Rexulti | $8 |
| Otsuka America Pharmaceutical | Meals · 2025-08-11 | Rexulti | $28 |
| Neuronetics | Meals · 2025-08-05 | Neurostar Tms Therapy System | $30 |
| Abbvie | Meals · 2025-08-05 | Vraylar | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-30 | Cobenfy | $121 |
| Abbvie | Meals · 2025-07-28 | Vraylar | $31 |
| Abbvie | Meals · 2025-07-22 | Vraylar | $14 |
| Teva Pharmaceuticals USA | Meals · 2025-07-22 | Uzedy | $16 |
| Janssen Pharmaceuticals | Meals · 2025-07-15 | Invega Sustenna | $36 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-07-07 | Rexulti | $11 |
| Alkermes | Meals · 2025-07-01 | Aristada | $22 |
| Abbvie | Meals · 2025-06-30 | Vraylar | $22 |
| Neurocrine BioSciences | Meals · 2025-06-29 | Ingrezza | $16 |
| Abbvie | Meals · 2025-06-24 | Vraylar | $24 |
| Abbvie | Meals · 2025-06-24 | Vraylar | $5 |
| Alkermes | Meals · 2025-06-24 | Aristada | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-23 | Trintellix | $15 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-18 | Caplyta | $29 |
| Abbvie | Meals · 2025-06-17 | Vraylar | $20 |
| Janssen Pharmaceuticals | Meals · 2025-06-16 | Spravato | $16 |
| Abbvie | Meals · 2025-06-10 | Vraylar | $20 |
| Abbvie | Meals · 2025-06-03 | Vraylar | $21 |
| Alkermes | Meals · 2025-06-03 | Aristada | $16 |
| Abbvie | Meals · 2025-05-20 | Vraylar | $21 |
| Abbvie | Meals · 2025-05-06 | Vraylar | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-04-28 | Uzedy | $27 |
| Abbvie | Meals · 2025-04-22 | Vraylar | $17 |
| Abbvie | Meals · 2025-04-15 | Vraylar | $22 |
| Abbvie | Meals · 2025-04-08 | Vraylar | $28 |
| Janssen Pharmaceuticals | Meals · 2025-04-07 | Invega Sustenna | $32 |
| Abbvie | Meals · 2025-04-01 | Vraylar | $19 |
| Abbvie | Meals · 2025-03-25 | Vraylar | $30 |
| Abbvie | Meals · 2025-03-18 | Vraylar | $32 |
| Teva Pharmaceuticals USA | Meals · 2025-03-17 | Uzedy | $14 |
| Abbvie | Meals · 2025-03-11 | Vraylar | $24 |
| Collegium Pharmaceutical | Meals · 2025-03-11 | Jornay Pm | $19 |
| Abbvie | Meals · 2025-03-04 | Vraylar | $25 |
| Teva Pharmaceuticals USA | Education · 2025-03-03 | None | $111 |
| Abbvie | Meals · 2025-02-28 | Vraylar | $20 |
| Axsome Therapeutics | Meals · 2025-02-24 | Auvelity | $18 |
| Teva Pharmaceuticals USA | Meals · 2025-02-20 | Uzedy | $122 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-10 | Cobenfy | $21 |
| Abbvie | Meals · 2025-02-04 | Vraylar | $17 |
| Neurocrine BioSciences | Meals · 2025-02-04 | Ingrezza | $122 |
| Janssen Pharmaceuticals | Meals · 2025-02-03 | Spravato | $16 |
| Otsuka America Pharmaceutical | Meals · 2025-02-03 | Abilify Asimtufii | $8 |
| Abbvie | Meals · 2025-01-27 | Vraylar | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-01-22 | Rexulti | $120 |
| Alkermes | Meals · 2025-01-14 | Aristada | $23 |
| Abbvie | Meals · 2025-01-13 | Vraylar | $29 |
| Otsuka America Pharmaceutical | Meals · 2025-01-13 | Rexulti | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-01-13 | Austedo Xr | $8 |
| Abbvie | Meals · 2025-01-07 | Vraylar | $23 |
See earlier years (2024)
2024: $1,591
| Abbvie | Vraylar | $517 | 25 payments
|
| Teva Pharmaceuticals USA | Uzedy | $402 | 15 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $252 | 6 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $136 | 8 payments
|
| Alkermes | Aristada | $91 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $78 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $62 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $28 | 1 payment
|
| Axsome Therapeutics | Auvelity | $24 | 1 payment
|
Professional record
- NPI
- 1053175323
- Licence
- CA 95028992
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 1098 Melody Ln Ste 102, Roseville, CA, 95678
- NPI first listed
- 2024-02-07
- NPI last updated
- 2024-09-23
- NPI record certified
- 2024-09-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6501 Coyle Ave, Carmichael, CA, 95608